NVX-CoV2373 ancestral and NVX-CoV2540 BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters
T. L. Bricker, A. Joshi, N. Soudani, S. Scheaffer, N. Patel, M. G. Xabier, G. Smith, M. Diamond, A. C. Boon
This study evaluates the efficacy of NVX-CoV2373 and NVX-CoV2540 nanoparticle vaccines against the Omicron BA.5 variant in Syrian hamsters, showing reduced viral infection and better protection compared to mRNA vaccines.
bioRxiv · Aug 7, 2023Microbiology